Global agreement signed

Article

Bausch + Lomb have signed a global agreement for the rights to distribute Leica's ophthalmic surgical microscopes.

Bausch + Lomb have signed a global agreement for the rights to distribute Leica's ophthalmic surgical microscopes.

Leica's ophthalmic portfolio will be available to B + L, ranging from routine cataract microscopes to high-end retinal systems and including the Leica M822 for cataract procedures which combines LED and halogen lighting for a stable red reflex.

Executive vice president and president of Bausch + Lomb, John Barr, stated, "We are happy to announce the partnership of two leading companies in the field of eye surgery. Bausch + Lomb is a perfect partner for companies, such as Leica Microsystems, looking to broaden their market reach through a powerful worldwide commercial infrastructure."

"Leica Microsystems is a trusted, established brand in the industry and the company is known for their innovative microscopes and scientific instruments," continued Mr Barr. "We are excited to offer Leica surgical microscopes, as they enhance our ability to offer a ‘one-stop shop’ for an ophthalmic surgeons’ needs, while also accelerating the growth of our business.”

Eoghan O'Lionaird, president of Leica Microsystems, commented, "Through this partnership with Bausch + Lomb, we will be able to provide more patients around the world with better access to our world-leading imaging systems. We are pleased to have such a respected and innovative company as Bausch + Lomb as our partner. Our customers, their patients, and our business will benefit from this collaboration as ophthalmic surgeons will have a single source supplier for their equipment needs."

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.